Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection

Abstract

In this review, the potential causes of ageing are discussed. We seek to gain insight into the main physiological functions of mitochondria and discuss alterations in their function and the genome, which are supposed to be the central mechanisms in senescence. We conclude by presenting the potential modulating role of the kynurenine pathway in the ageing processes. Mitochondrial dynamics are supposed to have important physiological roles in maintaining cell homeostasis. During ageing, a decrease in mitochondrial dynamics was reported, potentially compromising the function of mitochondria. Mitochondrial biogenesis not only encompasses mitochondrial dynamics, but also the regulation of transcription and translation of genes, and mitochondria are supposed to play a prominent role in cell death during senescence. Defects in the mtDNA replication machinery and failure in the repair of mtDNA might result in the accumulation of mutations, leading to mitochondrial dysfunction and bioenergetic failure of the cell. The role of reactive oxygen species (ROS) in the ageing processes is widely acknowledged. Exaggerated oxidative damage to mDNA is supposed to take place during senescence, including single-nucleotide base alterations, nucleotide base pair alterations, chain breaks and cross linkage. A broad repertoire for the repair of DNA faults has evolved, but they do not function efficiently during senescence. Poly (ADP-ribose) polymerase (PARP) is an enzyme that assists in DNA repair, i.e., it participates in the repair of single-stranded DNA nicks, initiating base excision repair (BER). In the case of extensive DNA damage, PARP-1 becomes overactivated and rapidly depletes the intracellular NAD+ and ATP pools. This results in a profound energy loss of the cell and leads to cell dysfunction, or even cell death. Alterations in the kynurenine system have been linked with ageing processes and several age-related disorders. The kynurenine pathway degrades tryptophan (TRP) to several metabolites, among others kynurenine (KYN), kynurenic acid (KYNA) and quinolinic acid (QUIN). The end product of the route is NAD+. The first metabolic reaction is mediated by TRP-2,3-dioxygenase (TDO) or indolamine-2,3-dioxygenases (IDO), the latter being induced by inflammation, and it is thought to have a significant role in several disorders and in ageing. Research is currently focusing on the KYN pathway, since several intermediates possess neuro- and immunoactive properties, and hence are capable of modulating the activity of certain brain cells and inflammatory responses. During ageing, and in many age-associated disorders like obesity, dyslipidaemia, hypertension, insulin resistance and neurodegenerative diseases, low-grade, sustained inflammation and upregulation of IDO have been reported. However, TRP downstream catabolites create a negative feedback loop by weakening the activated immune system through several actions, including a decline in the Th1 response and an enhancement of Th2-type processes. The broad actions of the KYN-intermediat...

Polydatin suppresses nucleus pulposus cell senescence, promotes matrix homeostasis and attenuates intervertebral disc degeneration in rats

“…Senescence and cellular metabolism of ECM are implicated in mitochondrial dysfunction . Exposure of cells to TNF‐α induces more generation of ROS, and overproduction of ROS can result in mitochondrial dysfunction . Defective mitochondria with lower mitochondrial membrane potential can produce much reactive oxygen species (ROS), which promotes the production of intracellular malondialdehyde (MDA) that is the cell membrane lipid peroxidation product.…”

Inhibition of tryptophan 2,3-dioxygenase impairs DNA damage tolerance and repair in glioma cells

“…We have investigated the relationship between TDO activity and the maintenance of genomic integrity in glioma-derived cellsuncovering evidence that KP signaling has a broad effect on the ability of glioma-derived cells to respond to HU-induced RS and damage generated by BCNU, a DNA alkylating agent used in the treatment of malignant brain tumors. The impact of KP signaling on central nervous system disorders, immune function, and tumor biology is known to be multi-faceted, involving interplay between transcriptional regulators, NAD + -dependent activities, mitochondrial function, heme biosynthesis, and energy utilization circuits (27,(62)(63)(64)(65). Our findings provide some new and intriguing insights into how metabolic changes in the tumor microenvironment can influence genomic stability in glioma cells and possibly influence responsiveness to chemotherapy.…”

“…4B and C; 10 µM: z-score = 7.00, p-value = 1.0 x 10 -29 ; 20 µM: z-score = 6.48, p-value = 2.0 x 10 -29 ). An increase in pyruvate dehydrogenase (PDH)-mediated acetyl-CoA biosynthesis was also observed signifying increased flux through the TCA cycle, which could be related to diminished production of the allosteric PDH inhibitor acetyl-CoA from KYN breakdown (27). Inhibition of TDO also increased the Nrf2-mediated oxidative stress response at both concentrations of 680C91 (10 µM: z-score = 2.50, p-value = 0.003; 20 µM: z-score = 2.33, p-value = 0.007).…”

Toxoplasma gondiiROP18 Inhibits Human Glioblastoma Cell Apoptosis through Mitochondrial Pathway by Targeting Host Cell P2X1

“…Poly (ADP-ribose) polymerases (PARPs) are an important family of nucleoproteins which are mostly present in the nucleus and less in the cytosol. It is composed of three functional domains, namely central auto-modification domain, C-terminal catalytic domain and N-terminal DNA binding domain which assists in binding to both single-and double-stranded breaks in DNA for DNA repair [39,40]. In our study, pro-PARP can be activated into cleaved PARP when SF268 cells was treated by ATP for 12hrs.…”